ArgusEye closes €2.8 million funding to accelerate bioprocessing

FHS
May 13, 2024
11:04 am

ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).

St. Jude announces $13 million investment to expand the understanding of G-protein coupled receptors

St. Jude Children’s Research Hospital today announced a nearly $13 million investment toward a new research collaboration with scientists at Columbia University, Duke University and

January 18, 2024

Clinical Trial Data Strategy: Shifting to Innovative Data Collection

Sabrina Steffen, Head of Data Strategy and Innovation for Data Management at IQVIA In drug development, there is a critical focus on protocol design, because

November 21, 2023

As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.